According to Pharma Mar's latest financial reports the company's current revenue (TTM ) is NZ$0.33 Billion. an increase over the revenue in the year 2023 that were of NZ$0.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | NZ$0.33 B | 22.96% |
2023 | NZ$0.27 B | -17.12% |
2022 | NZ$0.32 B | -15.98% |
2021 | NZ$0.38 B | -9% |
2020 | NZ$0.42 B | 200.38% |
2019 | NZ$0.14 B | -44.04% |
2018 | NZ$0.25 B | -11.81% |
2017 | NZ$0.28 B | 0.01% |
2016 | NZ$0.28 B | -12.02% |
2015 | NZ$0.32 B | 32.06% |
2014 | NZ$0.24 B | 9.56% |
2013 | NZ$0.22 B | -18.15% |
2012 | NZ$0.27 B | -17.53% |
2011 | NZ$0.33 B | 28.86% |
2010 | NZ$0.26 B | 8.65% |
2009 | NZ$0.24 B | -11.28% |
2008 | NZ$0.27 B |